Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Hims & Hers Shares Extend Decline Amid Novo Nordisk Patent Lawsuit Over Compounded Weight-Loss Drugs
Hims & Hers Health stock fell another 5.6% as Novo Nordisk filed a patent lawsuit seeking to block compounded versions of Wegovy, tightening regulatory pressure on the online health provider's GLP-1 offerings.
JPMorgan Faces Internal Pushback Over Full-Time Office Mandate
JPMorgan Chase employees warn that resisting CEO Jamie Dimon's five-day office requirement could harm careers, as a petition for hybrid work gains limited traction.
Meta Faces EU Pressure Over WhatsApp AI Access, Stock Dips Slightly
Meta shares edged lower as EU regulators consider forcing WhatsApp to open its business platform to rival AI assistants. Separately, WhatsApp won a court ruling to challenge a €225 million privacy fine.
Hims & Hers Stock Extends Slide Amid Weight-Loss Pill Halt, Regulatory Pressure
Hims & Hers Health shares fell another 4.2% premarket Tuesday, compounding a 16% drop Monday, after discontinuing its compounded semaglutide pill. The company faces a patent lawsuit from Novo Nordisk and potential FDA action.
Crypto Kiosk Fraud Prompts Regulatory Crackdown Across U.S. States
Americans lost over $333 million to cryptocurrency ATM scams in 2025, driving lawmakers in at least 15 states to propose stricter rules including registration mandates and enhanced warnings.
Kyndryl Shares Stabilize After Steep Plunge on Regulatory Scrutiny, Leadership Changes
Kyndryl's stock found modest footing in premarket trading following a 55% collapse, triggered by a delayed SEC filing and an internal controls review. The IT services firm also announced the departure of its CFO and global controller.
National Grid Shares Hold Steady Amid Regulatory Watch and Infrastructure Milestone
National Grid shares showed minimal movement as the company completed a key grid upgrade project. Investor focus remains on Ofgem's upcoming RIIO-3 license decision and UK interest rate volatility.
GSK's RSV Vaccine Advances in China Review, Analysts Adjust Targets
GSK's respiratory syncytial virus vaccine Arexvy has entered regulatory review in China, a key market for adult immunization. The stock declined Monday despite several brokerages raising price targets.
Telstra Shares Dip Amid Spectrum Fee Dispute Ahead of Earnings
Telstra shares edged lower as the telecom giant pushes for a cap on spectrum renewal costs, challenging regulator proposals ahead of its half-year results.
Hims & Hers Shares Plunge 16% After Halting $49 Weight-Loss Pill Amid Novo Nordisk Lawsuit
Hims & Hers Health stock tumbled in after-hours trading following the withdrawal of its compounded semaglutide product and a patent infringement lawsuit from Novo Nordisk. Leerink Partners reduced its price target on the company.
Meta Shares Gain as EU Considers Forcing WhatsApp to Open AI Access
Meta Platforms stock advanced 2.4% in after-hours trading following reports that European Union regulators are weighing interim measures to compel WhatsApp to allow competing AI assistants on its platform.